Lanzhou Foci Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000019W4
CNY
8.57
0.26 (3.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Lanzhou Foci Pharmaceutical Co., Ltd.

Why is Lanzhou Foci Pharmaceutical Co., Ltd. ?

1
Poor Management Efficiency with a low ROCE of 5.82%
  • The company has been able to generate a Return on Capital Employed (avg) of 5.82% signifying low profitability per unit of total capital (equity and debt)
2
Negative results in Sep 25
  • DEBTORS TURNOVER RATIO(HY) Lowest at 1.92 times
  • INTEREST COVERAGE RATIO(Q) Lowest at 272.16
  • PRE-TAX PROFIT(Q) At CNY 9.33 MM has Fallen at -47.37%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Lanzhou Foci Pharmaceutical Co., Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Lanzhou Foci Pharmaceutical Co., Ltd.
6.33%
0.61
38.27%
China Shanghai Composite
16.01%
1.07
14.97%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
6.09%
EBIT Growth (5y)
39.88%
EBIT to Interest (avg)
76.92
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
0.57
Tax Ratio
9.23%
Dividend Payout Ratio
10.20%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.82%
ROE (avg)
5.37%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
81
Industry P/E
Price to Book Value
2.42
EV to EBIT
137.56
EV to EBITDA
48.98
EV to Capital Employed
2.74
EV to Sales
4.54
PEG Ratio
6.27
Dividend Yield
0.14%
ROCE (Latest)
1.99%
ROE (Latest)
3.01%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 149.87 MM

RAW MATERIAL COST(Y)

Fallen by -12.53% (YoY

CASH AND EQV(HY)

Highest at CNY 832.79 MM

DEBT-EQUITY RATIO (HY)

Lowest at -22.14 %

-26What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 1.92 times

INTEREST COVERAGE RATIO(Q)

Lowest at 272.16

PRE-TAX PROFIT(Q)

At CNY 9.33 MM has Fallen at -47.37%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.71 times

NET SALES(Q)

Lowest at CNY 194.69 MM

INTEREST(Q)

Highest at CNY 1.3 MM

OPERATING PROFIT(Q)

Lowest at CNY 3.55 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 1.82 %

NET PROFIT(Q)

At CNY 7.98 MM has Fallen at -40.99%

Here's what is working for Lanzhou Foci Pharmaceutical Co., Ltd.

Operating Cash Flow
Highest at CNY 149.87 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Cash and Eqv
Highest at CNY 832.79 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -22.14 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -12.53% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Lanzhou Foci Pharmaceutical Co., Ltd.

Net Sales
At CNY 194.69 MM has Fallen at -13.41%
over average net sales of the previous four periods of CNY 224.83 MM
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Interest
At CNY 1.3 MM has Grown at 244.34%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio
Lowest at 272.16
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit
At CNY 9.33 MM has Fallen at -47.37%
over average net sales of the previous four periods of CNY 17.73 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Debtors Turnover Ratio
Lowest at 1.92 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Net Sales
Lowest at CNY 194.69 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Interest
Highest at CNY 1.3 MM
in the last five periods and Increased by 244.34% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Profit
Lowest at CNY 3.55 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 1.82 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit
At CNY 7.98 MM has Fallen at -40.99%
over average net sales of the previous four periods of CNY 13.52 MM
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

Inventory Turnover Ratio
Lowest at 1.71 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio